StockDriftsStockDriftsMyeongin Pharmaceutical (317450) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Myeongin Pharmaceutical is dated 2025-10-01; the most recent is 2026-05-08.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | BUY | 수증 | 이선영 Seonyoung Lee | - | 1.8M | ₩53,800 | -2.2% | ₩94.7B ($65.8M) |
| 2026-05-08 | BUY | 수증 | 이자영 Lee Ja-young | - | 1.5M | ₩53,800 | -2.2% | ₩80.7B ($56.0M) |
| 2026-05-08 | SELL | 증여 | 이행명 name of implementation | Chairman | -100.0K | ₩53,800 | +2.2% | ₩5.4B ($3.7M) |
| 2026-05-08 | SELL | 증여 | 이행명 name of implementation | Chairman | -630.0K | ₩53,800 | +2.2% | ₩33.9B ($23.5M) |
| 2026-05-08 | SELL | 증여 | 이행명 name of implementation | Chairman | -330.0K | ₩53,800 | +2.2% | ₩17.8B ($12.3M) |
| 2025-10-01 | BUY | 신규상장 | 이동철 Lee Dong-cheol | president | 50.0K | ₩121,900 | -49.1% | ₩6.1B ($4.2M) |
| 2025-10-01 | BUY | 신규상장 | 이행명 name of implementation | CEO | 7.4M | ₩121,900 | -49.1% | ₩905.5B ($628.8M) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.